# OnCo record srn-101 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/srn-101/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "srn-101" ;
  schema:name "SRN-101"@en ;
  schema:description "SRN-101 is an experimental AAV gene therapy from Siren Biotechnology, in phase 1 trials for recurrent high-grade glioma."@en ;
  schema:url <https://onco.cc/drugs/srn-101/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://sirenbiotechnology.com/pipeline-assets/>, <https://sirenbiotechnology.com/pipeline-assets/>, <https://clinicaltrials.gov/api/v2/studies/NCT07902037>, <https://clinicaltrials.gov/search?intr=SRN-101> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "AAV gene therapy (immuno-gene therapy)" ;
  onco:cancers <https://onco.cc/cancers/brain-tumours/> ;
  onco:companies <https://onco.cc/companies/siren-biotechnology/> ;
  onco:trials <https://onco.cc/trials/nct07902037/>, <https://onco.cc/trials/nct07826949/> .